RedHill Announces New USPTO Patent Grant for Talicia® for H. pylori Treatment Through 2042
USPTO issues new patent covering Talicia[1] as a method for eradicating H. pylori regardless of patient Body Mass Index (BMI)[2], supporting Talicia protection until May 2042
Related news for (RDHL)
- Don’t Miss Out: MoBot’s Latest Stock Updates 07/21/25 01:00 PM
- Top Biotech Movers: Transformative Breakthroughs Fuel Investor Interest Across Neurology, Autoimmunity, and Advanced Materials
- Breaking News: MoBot’s Latest Update as of 05/13/25 08:00 AM
- 24/7 Market News Snapshot 13 May, 2025 – Redhill Biopharma Ltd. (NASDAQ:RDHL)
- Today’s Top Performers: MoBot’s Market Review 04/16/25 08:00 AM